Claudia Vincenza Fiumara

Preclinical model in HCC: the SGK1 kinase inhibitor SI113 blocks tumor progression<i>in vitro</i>and<i>in vivo</i>and synergizes with radiotherapy

Cristina Talarico, Lucia D’Antona, Domenica Scumaci et al. · Oncotarget · 2015 · 62 citations · Full text

Medicine, Oncology, Pharmacology +17

DJ-1 Proteoforms in Breast Cancer Cells: The Escape of Metabolic Epigenetic Misregulation

Domenica Scumaci, Erika Olivo, Claudia Vincenza Fiumara et al. · Cells · 2020 · 31 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

In Preclinical Model of Ovarian Cancer, the SGK1 Inhibitor SI113 Counteracts the Development of Paclitaxel Resistance and Restores Drug Sensitivity

Lucia D’Antona, Vincenzo Dattilo, Giada Catalogna et al. · Translational Oncology · 2019 · 30 citations · Full text

Medicine, Oncology, Pharmacology +14

Histone proteomics reveals novel post-translational modifications in breast cancer

Valter Agosti, Erika Olivo, Antonio Concolino et al. · Aging · 2019 · 23 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17

Proteomics Analysis to Assess the Role of Mitochondria in BRCA1-Mediated Breast Tumorigenesis

Antonio Concolino, Erika Olivo, Laura Tammè et al. · Proteomes · 2018 · 21 citations · Full text

Life Sciences, Molecular Biology, Oncology +17